Optimized Therapy in Severe Traumatic Brain Injured Patients

PHASE4CompletedINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

January 31, 2005

Primary Completion Date

February 28, 2011

Study Completion Date

February 28, 2011

Conditions
Traumatic Brain InjuryComa
Interventions
DRUG

Dipeptiven

two groups: group 1: continuous infusion for 24 hours group 2: continuous infusion for 5 days

Trial Locations (1)

8006

University Hospital Zurich, Zurich

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Swiss National Science Foundation

OTHER

collaborator

Fresenius Kabi

INDUSTRY

collaborator

University Hospital, Zürich

OTHER

lead

University of Zurich

OTHER

NCT02130674 - Optimized Therapy in Severe Traumatic Brain Injured Patients | Biotech Hunter | Biotech Hunter